- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05815810
Novel Delivery Method of Transgender Voice Therapy Using a Mobile Application
December 15, 2025 updated by: Weill Medical College of Cornell University
The investigators hypothesize that the mobile application they developed for transgender and gender diverse individuals (TGGD) will be equivalent or better than traditional speech therapy in improving voice quality.
The investigators will measure both how the participants feel about their voices and how their voice actually sounds to see if the app is effective.
Study Overview
Status
Not yet recruiting
Intervention / Treatment
Detailed Description
The ultimate objective of this study is to use Community-Based Participatory Research (CBPR) methods to develop an effective user-friendly, health literate, inclusive and accessible mobile application (app) to improve access to gender affirming voice modification training for transgender and gender diverse (TGGD) individuals.
The immediate objectives are to understand the needs of TGGD individuals in voice care,and identify barriers to creating a pilot app with evidence-based educational content for VCMT and to evaluate subjective and objective voice outcomes of TGGD participants with app use compared to standard behavioral intervention with a speech pathologist.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Anaïs Rameau, MD
- Phone Number: 646-962-7464
- Email: anr2783@med.cornell.edu
Study Locations
-
-
New York
-
Ithaca, New York, United States, 14850
- Ithaca College
-
Contact:
- Mary Pitti, CCC-SLP
- Phone Number: 607-274-1765
- Email: mpitti@ithaca.edu
-
Principal Investigator:
- Mary Pitti, CCC-SLP
-
New York, New York, United States, 10022
- Weill Cornell Medicine
-
Contact:
- Anaïs Rameau, MD
- Phone Number: 646-962-7464
- Email: anr2783@med.cornell.edu
-
Principal Investigator:
- Anais Rameau, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Identify as a transgender individual
- Be 18 years or older
- Be able to read and write in English
- Have an iOS or Android Device
Exclusion Criteria:
- Identify as cisgender
- Experience hoarseness
- Experiencing any physical pain related to voice use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Transgender and gender diverse (TGGD) individuals using the pilot app
The investigators will develop Attuned, an open access voice and communication modification training (VCMT) app based on standard of care.
Participants will undergo VCMT via the mobile application, Attuned.
Participants will include healthy transgender and gender diverse (TGGD) individuals seeking voice modification to better reflect their identity.
|
Subjects will undergo voice and communication modification therapy via the Attuned application.
This consists of an 11 week program consisting of different modules to learn how to modify voice (e.g., pitch, intonation, resonance).
At the end of each module, participants will be given exercises to practice what they learned.
|
|
Active Comparator: Transgender and gender diverse (TGGD) individuals receiving standard voice modification
VCMT via speech pathology will be compared to the efficacy of an app-based VCMT program.
Participants will undergo VCMT in-person.
Participants will include healthy transgender and gender diverse (TGGD) individuals seeking voice modification to better reflect their identity.
|
Subjects will undergo standard of care in-person voice modification therapy at Ithaca College.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Transsexual Voice Questionnaire (TVQ) Scores
Time Frame: Baseline, Week 4, Week 11
|
The Transsexual Voice Questionnaire (TVQ) is a 30-item questionnaire that assesses self-perception of voice in transgender individuals.
Responses range from (1) rarely or never to (4) usually or always.
Scores range from 30 (no perceived voice difficulty) to 120 (high perceived voice difficulty).
|
Baseline, Week 4, Week 11
|
|
Change in Transgender Self Evaluation Questionnaire (TSEQ) Scores
Time Frame: Baseline, Week 4, Week 11
|
The Transgender Self Evaluation Questionnaire (TSEQ) is a 30-item questionnaire that assesses self perception in transgender and gender diverse individuals.
Responses range from (1) never (4) always.
Scores range from 30 (low voice satisfaction) to 120 (high voice satisfaction)
|
Baseline, Week 4, Week 11
|
|
Change in Fundamental Frequency
Time Frame: Baseline, Week 4, Week 11
|
The acoustic measure fundamental frequency will be obtained by analyzing participant's voice recordings via multi-speech acoustic analyses program of Kay-Pentax
|
Baseline, Week 4, Week 11
|
|
Change in Formants
Time Frame: Baseline, Week 4, Week 11
|
The acoustic measure formants will be obtained by analyzing participant's voice recordings via multi-speech acoustic analyses program of Kay-Pentax
|
Baseline, Week 4, Week 11
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Usability of Mobile Application as measured by the Mobile Application Rating Scale (MARS)
Time Frame: Week 11
|
The Mobile Application Rating Scale (MARS) is a 19-item scale that allows app users to rate the usability of a mobile application.
Responses range from 1 (inadequate) to 5 (excellent).
Scores range from 19-95 with a score of 19 corresponding to a poor and inadequate app and 95 of an excellent apps with great usability.
|
Week 11
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Anaïs Rameau, MD, Weill Medical College of Cornell University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2028
Study Registration Dates
First Submitted
April 3, 2023
First Submitted That Met QC Criteria
April 3, 2023
First Posted (Actual)
April 18, 2023
Study Record Updates
Last Update Posted (Actual)
December 22, 2025
Last Update Submitted That Met QC Criteria
December 15, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 21-12024240
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Transitioning Voice of Transgender and Gender Diverse People
-
University of MinnesotaRecruitingTransgender | Cancer Screening | Gender Diverse PopulationsUnited States
-
Hacettepe UniversityCompletedGender Dysphoria | Hormone Replacement Therapy | Transgender Persons | Voice Disorder Due to TranssexualismTurkey
Clinical Trials on Attuned: A mobile application
-
Dr Abdurrahman Yurtaslan Ankara Oncology Training...CompletedPatient Satisfaction | Bowel Preparation | Patient ExperienceTurkey
-
Stanford UniversityNot yet recruitingHeart FailureUnited States
-
Ankara UniversityRecruitingColorectal Cancer | NursingTurkey
-
Anglia Ruskin UniversitySouthend NHS Foundation Trust; Basildon and Thurrock Hospitals NHS FoundationTrustNot yet recruiting
-
Shenyang Northern HospitalRecruitingSTEMI - ST Elevation Myocardial InfarctionChina
-
Oslo Metropolitan UniversityRecruiting
-
University of ValenciaRecruitingSuicide | Suicidal Ideation and BehaviorSpain
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de Rhumatologie; URC-CIC Paris Descartes Necker Cochin; Arthritis... and other collaboratorsNot yet recruitingChronic Low Back PainFrance
-
Universidad de GranadaAmgen; Fundación Pública Andaluza para la Investigación Biomédica Andalucía... and other collaboratorsNot yet recruiting
-
Bournemouth UniversityCompletedNutritional Status | Nutrition Assessment